|
Distinguished Seminar co-organized by
Medical and Health Research Network & Asia Society
Date: September 26, 2003 (Friday)
Time: 12:00 to 14:00
Cocktails (cash bar) at 12:00, Luncheon at 12:30, Close at 14:00
Venue: Island Shangri-La Hotel, Level 5, Ballroom C, Pacific Place
The effect of SARS on China and other
Asian countries was devastating, and concerns remain that it may
again return. Yet SARS is only one of a succession of completely
new infectious diseases that have emerged in the continuing struggle
between man and microbes. They raise some critical questions to
be addressed, including:
- What are the threats to the public's
health that are likely to be of greatest concern to Asia in the
next decades?
- How can countries prevent or prepare for them?
- What are the investments that will be required to do so?
- What is the impact of investments in public health on the health
of people and the health of Asian economies?
Dr Bloom is Dean of the Faculty and
Professor of Immunology and Infectious Diseases in the Department
of Population and International Health at the Harvard School of
Public Health. "Preventing and reducing the major burdens of
disease and disability and narrowing disparities in health are the
chief challenges for public health in the 21st century," says
Dean Bloom. The wide range of disciplines studied at the Harvard
School of Public Health by a diverse student body and faculty makes
the School a vital contributor to this critical national and global
mission.
Dr Bloom received his B.A. degree,
and an honorary S.D., from Amherst College; an honorary A.M. from
Harvard University; and his Ph.D. from the Rockefeller University.
He currently serves on the Scientific Advisory Board of the National
Center for Infectious Diseases of the Centers for Disease Control
and Prevention, the Scientific Advisory Board of the Ellison Medical
Foundation, and the Medical Advisory Board of the Howard Hughes
Medical Institute. Dr Bloom received the first Bristol-Myers Squibb
Award for Distinguished Research in Infectious Diseases, shared
the Novartis Award in Immunology in 1998, and was the recipient
of the Robert Koch Gold Medal for lifetime research in infectious
diseases in 1999.
Photo Gallery
|
